Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
M. Fahlén, B. Wallberg, E. von Schoultz, K. Carlström, G. Svensson, N. Wilking & Y. Brandberg. (2011) Health-related quality of life during hormone therapy after breast cancer: a randomized trial. Climacteric 14:1, pages 164-170.
Read now
Read now
Peter S Grimison & Martin R Stockler. (2007) Quality of life and adjuvant systemic therapy for early-stage breast cancer. Expert Review of Anticancer Therapy 7:8, pages 1123-1134.
Read now
Read now
Aina Johnsson, Tommy Fornander, Mariann Olsson, Marianne Nystedt, Hemming Johansson & Lars Erik Rutqvist. (2007) Factors associated with return to work after breast cancer treatment. Acta Oncologica 46:1, pages 90-96.
Read now
Read now
Achim Rody, Sibylle Loibl, Gunter von Minckwitz & Manfred Kaufmann. (2005) Use of goserelin in the treatment of breast cancer. Expert Review of Anticancer Therapy 5:4, pages 591-604.
Read now
Read now
Articles from other publishers (30)
Seung Mi Yeo, Ji Young Lim, Seok Won Kim, Byung Joo Chae, Jonghan Yu, Jai Min Ryu & Ji Hye Hwang. (2023) Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study. Journal of Breast Cancer 26:2, pages 93.
Crossref
Crossref
Annelie Johansson, Huma Dar, Laura J. van ’t Veer, Nicholas P. Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau, Christopher C. Benz, Laura J. Esserman, Olle Stål, Bo Nordenskjöld, Tommy Fornander & Linda S. Lindström. (2022) Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Journal of Clinical Oncology 40:35, pages 4071-4082.
Crossref
Crossref
Jasmine S. Sukumar, Dionisia Quiroga, Mahmoud Kassem, Michael Grimm, Namrata Vilas Shinde, Leslie Appiah, Marilly Palettas, Julie Stephens, Margaret E. Gatti-Mays, Ashley Pariser, Mathew Cherian, Daniel G. Stover, Nicole Williams, Jeffrey Van Deusen, Robert Wesolowski, Maryam Lustberg, Bhuvaneswari Ramaswamy & Sagar Sardesai. (2021) Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer. Breast Cancer Research and Treatment 190:2, pages 183-188.
Crossref
Crossref
Claudia Carmassi, Annalisa Cordone, Valerio Dell'Oste, Virginia Pedrinelli, Francesco Pardini, Marly Simoncini & Liliana Dell'Osso. (2021) Prescribing Tamoxifen in Patients With Mood Disorders. Journal of Clinical Psychopharmacology 41:4, pages 450-460.
Crossref
Crossref
Andrew M. Novick, Anthony T. Scott, C. Neill Epperson & Christopher D. Schneck. (2020) Neuropsychiatric effects of tamoxifen: Challenges and opportunities. Frontiers in Neuroendocrinology 59, pages 100869.
Crossref
Crossref
Sandra OttoSandra Otto. 2018. Arbeiten trotz Krebserkrankung. Arbeiten trotz Krebserkrankung
97
140
.
H Yang, X Zong, Y Yu, G Shao, L Zhang, C Qian, Y Bian, X Xu, W Sun, X Meng, X Ding, D Chen, D Zou, S Xie, Y Zheng, J Zhang, X He, C Sun, X Yu & J Ni. (2013) Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial. British Journal of Cancer 109:3, pages 582-588.
Crossref
Crossref
Aina Johnsson, Artur Tenenbaum & Hugo Westerlund. (2011) Improvements in physical and mental health following a rehabilitation programme for breast cancer patients. European Journal of Oncology Nursing 15:1, pages 12-15.
Crossref
Crossref
Kathryn J. Ruddy, Shari Gelber, Elizabeth S. Ginsburg, Lidia Schapira, Mary E. Abusief, Meghan E. Meyer & Ann H. Partridge. (2011) Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors. Menopause 18:1, pages 105-108.
Crossref
Crossref
Zsuzsanna Kahán. 2011. Breast Cancer, a Heterogeneous Disease Entity. Breast Cancer, a Heterogeneous Disease Entity
283
304
.
A. JOHNSSON, T. FORNANDER, L.E. RUTQVIST & M. OLSSON. (2010) Factors influencing return to work: a narrative study of women treated for breast cancer. European Journal of Cancer Care 19:3, pages 317-323.
Crossref
Crossref
Maire B. Mac Bride, Deborah J. Rhodes & Lynne T. Shuster. (2010) Vulvovaginal Atrophy. Mayo Clinic Proceedings 85:1, pages 87-94.
Crossref
Crossref
Ciska Buijs, Constantijne H. Mom, Pax H. B. Willemse, H. Marike Boezen, J. Marina Maurer, A. N. Machteld Wymenga, Robert S. de Jong, Peter Nieboer, Elisabeth G. E. de Vries & Marian J. E. Mourits. (2008) Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Breast Cancer Research and Treatment 115:3, pages 573-580.
Crossref
Crossref
Christien Schilder, Sanne Schagen & Frits van Dam. 2009. Cognition and Cancer. Cognition and Cancer
115
141
.
Jesse R. Fann, Anne M. Thomas-Rich, Wayne J. Katon, Deborah Cowley, Mary Pepping, Bonnie A. McGregor & Julie Gralow. (2008) Major depression after breast cancer: a review of epidemiology and treatment. General Hospital Psychiatry 30:2, pages 112-126.
Crossref
Crossref
Zvezdana Snoj, Maja Primic akelj, Milan Lièina & Peter Pregelj. (2008) Psychosocial correlates of progesterone receptors in breast cancer. Depression and Anxiety, pages n/a-n/a.
Crossref
Crossref
Carrie Tompkins Stricker. (2007) Endocrine Effects of Breast Cancer Treatment. Seminars in Oncology Nursing 23:1, pages 55-70.
Crossref
Crossref
Timothy J. Whelan & Kathleen I. Pritchard. (2006) Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues. Clinical Cancer Research 12:3, pages 1056s-1060s.
Crossref
Crossref
Constantijne H. Mom, Ciska Buijs, Pax H.B. Willemse, Marian J.E. Mourits & Elisabeth G.E. de Vries. (2006) Hot flushes in breast cancer patients. Critical Reviews in Oncology/Hematology 57:1, pages 63-77.
Crossref
Crossref
Michael Kotlyar, Maurice Dysken & David E. Adson. (2005) Update on Drug-Induced Depression in the Elderly. The American Journal of Geriatric Pharmacotherapy 3:4, pages 288-300.
Crossref
Crossref
Patricia A. Ganz & Pamela J. Goodwin. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer
93
125
.
Pennifer Erickson. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer
31
68
.
Jamie L Eberling, Christine Wu, Regina Tong-Turnbeaugh & William J Jagust. (2004) Estrogen- and tamoxifen-associated effects on brain structure and function. NeuroImage 21:1, pages 364-371.
Crossref
Crossref
Marianne NystedtGunilla BerglundChristina BolundTommy FornanderLars Erik Rutqvist. (2003) Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized Study. Journal of Clinical Oncology 21:9, pages 1836-1844.
Crossref
Crossref
P. J. Goodwin, J. T. Black, L. J. Bordeleau & P. A. Ganz. (2003) Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock. JNCI Journal of the National Cancer Institute 95:4, pages 263-281.
Crossref
Crossref
W. JonatM. KaufmannW. SauerbreiR. BlameyJ. CuzickM. NamerI. FogelmanJ. C. de HaesA. de MatteisA. StewartW. EiermannI. SzakolczaiM. PalmerM. SchumacherM. GeberthB. Lisboa. (2002) Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study. Journal of Clinical Oncology 20:24, pages 4628-4635.
Crossref
Crossref
J.A. Söreide, J.E. Varhaug, H.E. Fjösne, B. Erikstein, A.-B. Jacobsen, E. Skovlund & S. Kvinnsland. (2002) Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study. European Journal of Surgical Oncology (EJSO) 28:5, pages 505-510.
Crossref
Crossref
R.W. Blamey. (2002) Guidelines on endocrine therapy of breast cancerEUSOMA. European Journal of Cancer 38:5, pages 615-634.
Crossref
Crossref
James A. Bennett, Fassil B. Mesfin, Thomas T. Andersen, John F. Gierthy & Herbert I. Jacobson. (2002) A peptide derived from α-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen. Proceedings of the National Academy of Sciences 99:4, pages 2211-2215.
Crossref
Crossref
Gunilla BerglundMarianne NystedtChristina BolundPer-Olow SjödénLars-Erik Rutquist. (2001) Effect of Endocrine Treatment on Sexuality in Premenopausal Breast Cancer Patients: A Prospective Randomized Study. Journal of Clinical Oncology 19:11, pages 2788-2796.
Crossref
Crossref